Home > Investor > Financial news

Financial news

E.g., 02/22/2025
E.g., 02/22/2025
2025
February
20 February 2025 Sales revenues for January 2025
January
31 January 2025 Notification for a significant shareholding from CUPF Alianz Bulgaria
20 January 2025 Sales revenues for December 2024
15 January 2025 Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
2024
December
20 December 2024 Decision on additional contribution to the capital of Sopharma Rus OOO
19 December 2024 Transaction within the scope of art. 114, para. 2 of the Law on Public offering of securities
19 December 2024 Sales revenues for November 2024
November
29 November 2024 Notification for Initiation of acquisition transaction
20 November 2024 Sales revenues for October 2024
October
30 October 2024 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "Sopharma" AD by exercising warrants from the issue ISIN BG9200001212
25 October 2024 Notification on the terms and conditions for distribution of the dividend voted at the Extraordinary General Meeting of Shareholders of "Sopharma" AD held on October 25, 2024
21 October 2024 Sales revenues for September 2024
14 October 2024 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOPHARMA" AD, by exercising warrants from the issue with ISIN BG9200001212
4 October 2024 Notification for initiation of acquisition transaction
September
20 September 2024 Sales revenues for August 2024
9 September 2024 Notification of sale of treasury shares as of 9 September 2024
August
20 August 2024 Sales revenues for July 2024
19 August 2024 "Sopharma" AD starts the payment of the dividend for 2023 on August 26, 2024
July
22 July 2024 Sales revenues for June 2024
1 July 2024 Notification of sale of treasury shares as of 1 July 2024
June
28 June 2024 Notification on the terms and conditions for distribution of the dividend
27 June 2024 Notification of sale of treasury shares as of 27 June 2024
26 June 2024 Notification of sale of treasury shares as of 26 June 2024
25 June 2024 Notification of sale of treasury shares as of 25 June 2024
20 June 2024 Sales revenues for May 2024
18 June 2024 Notification of buy-back of treasury shares as of 18 June 2024
17 June 2024 Notification of sale of treasury shares as of 17 June 2024
14 June 2024 Notification of sale of treasury shares as of 14 June 2024
14 June 2024 Notification for a significant shareholding from "Donev Investments Holding" AD as of 14 June 2024
12 June 2024 Notification of sale of treasury shares as of 12 June 2024
May
21 May 2024 Sales revenues for April 2024
April
22 April 2024 Sales revenues for March 2024
March
20 March 2024 Sales revenues for February 2024
February
27 February 2024 Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
19 February 2024 Sales revenues for January 2024
January
26 January 2024 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOPHARMA" AD by exercising warrants from the issue with ISIN BG9200001212
23 January 2024 Sales revenues for December 2023
15 January 2024 Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD
10 January 2024 "Sopharma" AD starts the payment of the dividend for the 6 months of 2023 on January 22, 2024
2023
December
22 December 2023 Notification for Buy-back of treasury shares on 22.12.2023
22 December 2023 Notification for buy-back of treasury shares on December 21
21 December 2023 Notification for buy-back of treasury shares
21 December 2023 Notification for buy-back of treasury shares
20 December 2023 Notification for buy-back treasury shares
20 December 2023 Sales revenues for November 2023
20 December 2023 Treasury shares December 19, 2023
19 December 2023 Notification for buy-back treasury shares
18 December 2023 Notification for Buy-back treasury shares on 19 December 2023
14 December 2023 Notification for buy-back of treasury shares on December 13, 2023
13 December 2023 Notification for buy-back of treasury shares
12 December 2023 Notification for buy-back of treasury shares
12 December 2023 Treasury shares December 11, 2023
11 December 2023 Notification for buy-back of treasury shares on December 12, 2023
11 December 2023 Treasury shares December 8, 2023
8 December 2023 Notification for buy-back of treasury shares
7 December 2023 Notification for buy-back of treasury shares
4 December 2023 Treasury shares
November
24 November 2023 Notification on the terms and conditions for distribution of the dividend
20 November 2023 Sales revenues for October 2023
7 November 2023 Serbian Commission for Protection of Competition allowed deal with Pharmanova
October
20 October 2023 Sales revenues for September 2023
16 October 2023 Notification for a significant shareholding from CUPF Alianz Bulgaria
16 October 2023 Optimization of the activity in foreign markets
13 October 2023 Notification for a significant shareholding from “Telecomplect Invest” AD
13 October 2023 Notification for a significant shareholding from Ognian Donev
6 October 2023 New capital of "Sopharma" AD entered in the Commercial Register
2 October 2023 Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
September
29 September 2023 A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company
20 September 2023 Sales revenues for August 2023
August
30 August 2023 Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD by exercising warrants from the issue with ISIN BG9200001212
23 August 2023 Completion of the infusion conversion procedure of “Biopharm Engineering” AD
21 August 2023 Sales revenues for July 2023
July
26 July 2023 "Sopharma" AD starts the payment of the 2022 dividend on July 31, 2023
20 July 2023 Sales revenues for June 2023
14 July 2023 Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia
June
20 June 2023 Sales revenues for May 2023
14 June 2023 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
9 June 2023 A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company
6 June 2023 Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023
2 June 2023 Notification on the terms and conditions for distribution of the dividend
1 June 2023 Analysis of potential acquisition opportunities on the territory of the Republic of Serbia
May
22 May 2023 Sales revenues for April 2023
April
20 April 2023 Sales revenues for March 2023
March
20 March 2023 Sales revenues for February 2023
February
21 February 2023 Notification for share participation from “Telso” AD
21 February 2023 Notification for share participation from “Donev investments holding” AD
6 February 2023 Sales revenues for January 2023
1 February 2023 Dissimination of monthly sales information
January
27 January 2023 "Sopharma" AD submitted for approval to the Financial Supervision Commission for an Agreement for conversion by merger of the subsidiary company "Biopharm-engineering" AD
20 January 2023 Publication of the Tender offering addressed to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD and Opinion of the Board of Directors in connection with Art. 154 of the Law on Public Offering of Securities and Art. 36 of Ordinance 13 o
13 January 2023 Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD
11 January 2023 Sales revenues for December 2022
2022
December
5 December 2022 Sales revenues for November 2022
November
29 November 2022 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
28 November 2022 Tender offer to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD
7 November 2022 Sales revenues for October 2022
October
26 October 2022 Merger of the subsidiary "Biopharm-engineering" AD into "Sopharma" AD
5 October 2022 Sales revenues for September 2022
September
29 September 2022 Shareholding notification from “Telso” AD
7 September 2022 Sales revenues for August 2022
August
26 August 2022 Results of the tender offering extended to the shareholders of “Sopharma Properties” REIT
5 August 2022 Sales revenues for July 2022
July
29 July 2022 Sopharma AD extends a tender offering to the shareholders of Sopharma properties REIT
7 July 2022 The Board of Directors of “Sopharma” AD adopted a decision to issue a second warrants issue
5 July 2022 Sales revenues for June 2022
June
14 June 2022 Treasury shares
10 June 2022 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
7 June 2022 Treasury shares
6 June 2022 Sales revenues for May 2022
3 June 2022 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
May
5 May 2022 Sales revenues for April 2022
April
5 April 2022 Sales revenues for March 2022
March
7 March 2022 Sales revenues for February 2022
1 March 2022 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
February
7 February 2022 Sales revenues for January 2022
January
18 January 2022 „Sopharma“ AD starts the payment of amounts from the rights with ISIN BG4000006214 sold at service auction
10 January 2022 Sales revenues for December 2021
6 January 2022 Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
2021
December
30 December 2021 The subscription for the public offering of warrants is successfully completed
23 December 2021 Sale of the share in the capital of the subsidiary SIA „Briz“
21 December 2021 Notification for share participation from “Rompharm Company” OOD
6 December 2021 Sales revenues for November 2021
6 December 2021 Treasury shares
2 December 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
2 December 2021 Treasury shares
November
30 November 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
5 November 2021 Sales revenues for October 2021
5 November 2021 Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma” AD
October
5 October 2021 Sales revenues for September 2021
September
30 September 2021 Treasury shares
28 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
27 September 2021 Treasury shares
23 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
20 September 2021 Treasury shares
16 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
13 September 2021 Treasury shares
13 September 2021 Treasury shares
9 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
9 September 2021 Sales revenues for August 2021
7 September 2021 Treasury shares
2 September 2021 Notification under Art. 111 para. 6 of LPOS for repurchase of shares
August
5 August 2021 Sales revenues for July 2021
3 August 2021 The Board of Directors of „Sopharma“ AD approved a prospectus for the issue of warrants
July
5 July 2021 Sales revenues for June 2021
June
7 June 2021 Sales revenues for May 2021
1 June 2021 Annual General Meeting of Shareholders convened for 4 June 2021 from 11:00 a.m. (8:00 a.m. UTC)
May
21 May 2021 The Board of Directors of “Sopharma” AD adopted a decision to issue warrants
13 May 2021 Sales revenues for April 2021
April
5 April 2021 Sales revenues for March 2021
2 April 2021 Notification on the adoption of a decision for amendments to the Articles of Association of the Company
March
26 March 2021 Exercising the right to vote by correspondence at the Extraordinary General Meeting of Shareholders convened on 2 April 2021 from 11:00 a.m. (8:00 a.m. UTC)
15 March 2021 Common policy agreement for the management of “Momina krepost” AD
5 March 2021 Sales revenues for February 2021
February
5 February 2021 Sales revenues for January 2021
January
11 January 2021 Sales revenues for December 2020
8 January 2021 „Sopharma” AD now owns 100% of the capital of the subsidiary BRIZ, Latvia
2020
December
29 December 2020 “Sopharma” AD sold the shares of its subsidiary "Aromania" AD
23 December 2020 The Board of Directors gave a mandate for negotiations for the sale of the shares owned by the Company in its subsidiaries "Veta Pharma" AD and "Aromania" AD
7 December 2020 The Investor Relations Director of “Sopharma” AD was awarded "Best Investor Relations Director for 2020" during the most important event of ABIRD - IR AWARDS 2020
7 December 2020 Sales revenues for November 2020
November
16 November 2020 W dniu 23. listopada 2020 spółka Sopharma S.A. rozpoczyna wypłatę dywidendy 6-miesięcznej
5 November 2020 Sales revenues for October 2020
October
5 October 2020 Sales revenues for September 2020
September
30 September 2020 Notification for acquisition of own shares
28 September 2020 Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD
28 September 2020 Notification for acquisition of own shares
25 September 2020 Notification for acquisition of own shares
25 September 2020 Notification on the terms and conditions for distribution of the dividend
24 September 2020 Notification for acquisition of own shares
23 September 2020 Notification for acquisition of own shares
14 September 2020 Online meeting with investors and exercising the right to vote by correspondence at the Extraordinary General Meetings of Shareholders convened on 25 September, 2020 from 11:00 and 11:30
8 September 2020 Sales revenues for August 2020
August
5 August 2020 Sales revenues for July 2020
July
22 July 2020 „Sopharma“ AD starts the payment of the gross dividend on August 3, 2020
7 July 2020 Notification for technical error correction
6 July 2020 Sales revenues for June 2020
1 July 2020 Notification for acquisition of own shares
June
30 June 2020 Notification for acquisition of own shares
29 June 2020 Notification for acquisition of own shares
26 June 2020 Notification for acquisition of own shares
25 June 2020 Notification for acquisition of own shares
23 June 2020 Notification for acquisition of own shares
22 June 2020 Notification for acquisition of own shares
19 June 2020 Notification for acquisition of own shares
19 June 2020 Notification for acquisition of own shares
18 June 2020 Notification for technical error correction
16 June 2020 The Board of directors of “Sopharma” AD assigned a procurator of the Company
16 June 2020 Notification for acquisition of own shares
5 June 2020 Sales revenues for May 2020
5 June 2020 Notification on the terms and conditions for distribution of the dividend
2 June 2020 Notification for acquisition of own shares
May
26 May 2020 Online meeting with investors and exercising the right to vote by correspondence at the General Meeting of Shareholders convened on June 5, 2020
5 May 2020 Sales revenues for April 2020
April
29 April 2020 Publishing of the Consolidated Audited Financial Statements for 2019 made public in the terms envisaged in §45, item 2 of the TAP of the Law for the measures and actions under extraordinary circumstances
6 April 2020 Sales revenues for March 2020
March
5 March 2020 Sales revenues for February 2020
February
5 February 2020 Sales revenues for January 2020
January
16 January 2020 Sopharma AD starts the payment of the 6-month dividend on January 22, 2020